PinnyPeptide

GHK-Cu vs Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

GHK-Cu

Cosmetic

Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties.

Peptide B

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)

Peptide Blends

Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial.

Typical vial

50 mg

Typical dose

200-500 mcg

Half-life

~30-60 minutes (plasma)

FDA status

Not FDA approved as a drug. Widely used as a cosmetic ingred…

Typical vial

80 mg

Typical dose

500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg

Half-life

KPV ~minutes; BPC-157 ~4 h; TB-500 ~6-8 h; GHK-Cu ~minutes systemically

FDA status

No component FDA approved for human use. FDA issued a warnin…

GHK-Cu effects

  • Stimulates collagen and elastin synthesis for skin rejuvenation
  • Promotes wound healing and tissue remodeling
  • Enhances angiogenesis and blood vessel formation
  • Modulates expression of over 4,000 genes involved in tissue repair
  • Provides antioxidant defense via superoxide dismutase activation
  • Reduces fine lines, wrinkles, and photodamage

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) effects

  • Broad anti-inflammatory action across NF-κB, nitric oxide, and copper-modulation pathways
  • Soft-tissue healing and tendon recovery (BPC + TB contribution)
  • Stimulates collagen synthesis and skin elasticity (GHK-Cu contribution)
  • Anti-inflammatory action in the gut and inflamed skin (KPV contribution)
  • Modulates the gut-skin axis (anecdotal, component-derived)
  • Reduces scar formation and supports remodelling
  • Promotes angiogenesis and improved blood flow to repair sites

GHK-Cu side effects

  • Mild skin irritation with topical use (uncommon)
  • Injection site discomfort with subcutaneous administration
  • Uncommon metallic taste
  • Rare contact sensitivity in predisposed individuals

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) side effects

  • Injection site irritation (occasionally with mild bluish tint from copper)
  • Temporary lightheadedness
  • Mild lethargy in first 1-2 weeks
  • Headache
  • Nausea at upper dosing range
  • Possible flushing from MSH-pathway activity (KPV)

GHK-Cu dosing ranges

Skin rejuvenation (topical)

1-2% concentration · Once or twice daily · Ongoing

Systemic tissue support (SubQ)

200-500 mcg · Once daily · 4-6 weeks

Wound healing support (SubQ)

200-500 mcg · Once daily near wound site · 2-4 weeks

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) dosing ranges

Inflammation + recovery loading

500 mcg KPV + 250 mcg BPC + 2 mg TB-500 + 1-2 mg GHK-Cu · KPV + BPC + GHK daily, TB-500 twice weekly · 6-8 weeks

Gut-skin axis protocol

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · Daily, with TB-500 weekly · 8-12 weeks

Maintenance

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · KPV + BPC 3-4x weekly, others weekly · Ongoing cycles

Full GHK-Cu guide → Full Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) guide →

GHK-Cu vs Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) — common questions

What is the difference between GHK-Cu and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

GHK-Cu: Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties. Typical dose 200-500 mcg. Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial. Typical dose 500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg. Both fall under the Cosmetic and Peptide Blends categories.

Can you stack GHK-Cu and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

Stacking GHK-Cu with Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, GHK-Cu or Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

GHK-Cu is typically dosed: Once or twice daily for Skin rejuvenation (topical); Once daily for Systemic tissue support (SubQ); Once daily near wound site for Wound healing support (SubQ). Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) is typically dosed: KPV + BPC + GHK daily, TB-500 twice weekly for Inflammation + recovery loading; Daily, with TB-500 weekly for Gut-skin axis protocol; KPV + BPC 3-4x weekly, others weekly for Maintenance.

Are GHK-Cu and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) FDA approved?

GHK-Cu: Not FDA approved as a drug. Widely used as a cosmetic ingredient without requiring drug approval for topical formulations. Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): No component FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products.

Related peptide comparisons

bpc-157 vs ghk-cuepithalon vs ghk-cughk-cu vs glow-blendghk-cu vs matrixylghk-cu vs melanotan-iibpc-157 vs klow-blend

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free